Do people regard cheaper medicines effective? Population survey on public opinion of generic substitution in Finland

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 2, 2011, Pages 185-191

  Heikkilä, Reeta ^a   Mäntyselkä, Pekka ^a,b   Ahonen, Riitta ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Drug; Experience; Generic substitution; Medicine; Opinion; Population based survey

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GENERIC DRUG; PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; DRUG COST; DRUG EFFICACY; FEMALE; FINLAND; GENDER; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACIST; PHARMACIST ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT REFUSAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CONSUMER PRODUCT SAFETY; COST SAVINGS; DRUG COSTS; DRUG SUBSTITUTION; DRUGS, GENERIC; FEMALE; FINLAND; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; LOGISTIC MODELS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; ODDS RATIO; PATIENT SATISFACTION; PUBLIC OPINION; QUESTIONNAIRES; RISK ASSESSMENT; SEX FACTORS; TIME FACTORS; TREATMENT REFUSAL; YOUNG ADULT;

EID: 78751690811     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2084     Document Type: Article

References (23)

1. Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, et al. Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland. Health Policy 2007; 82: 366-374. DOI: 10.1016/j.healthpol.2006.10.006.
2. Suomen Lääkäriliitto (The Finnish Medical Association). Lausunto luonnoksesta hallituksen esitykseksi eduskunnalle lääkelain ja sairausvakuutuslain muuttamiseksi. Helsinki 30.8.2002.
3. Lääketeollisuus ry (Pharma Industry Finland). Lausunto luonnoksesta lakiehdotukseksi geneerisen substituution toteuttamiseksi Suomessa. Helsinki 30.8.2002.
4. The Social Insurance Institution, Finland. Reimbursements for medicine expences. (accessed 20 August 2010).
5. Andersen ML, Laursen K, Schaumann M, et al. How do patients evaluate the newly introduced system of substituting prescriptions? Ugeskr Laeger 2000; 162: 6066-6069.
6. Madsen S, Huse J, Roksvaag P. Pharmacy customers' attitude to generics. Tidsskr Nor Laegeforen 2003; 123: 792-793.
7. Hassali A, Kong D, Stewart K. Generic medicines: Perception of consumers in Melbourne, Australia. Int J Pharm Pract 2005; 28: 257-264. DOI: 10.1211/ijpp.13.4.0004.
8. Himmel W, Simmenroth-Nayda A, Niebling W, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 2005; 43: 472-479.
9. Shrank WH, Cox ER, Fischer MA, et al. Patients' perceptions of generic medications. Health Aff 2009; 28: 546-556. DOI: 10.1377/hlthaff.28.2.546.
10. Kjoenniksen I, Lindbaek M, Granas AG. Patients'attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 2006; 28: 284-289.DOI: 10.1007/s11096-006-9043-5.
11. Hakonsen H, Eilertsen M, Borge H, et al. Generic substitution: Additional challenge for adherence in hypertensive patients? Curr Med Res Opin 2009; 25: 2515-2521.DOI: 10.1185/03007990903192223.
12. Van Wijk BL, Klungel OH, Heerdink ER, et al. Generic substitution of antihypertensive drugs: Does it affect adherence? Ann Pharmacother 2006; 40: 15-20. DOI: 10.1345/aph.1G163.
13. European commission, Directorate-General Health and Consumer Protection and Austrian Federal Ministry of Health, Family and Youth. Pharmaceutical Pricing and reimbursement Information (PPRI) Report. Vienna; June 2008; (accessed 19 January 2010).
14. Simoens S, De Coster S. Sustaining Generic Medicines Markets in Europe. Belgium; April 2006; (accessed 19 January 2010).
15. Martikainen J, Rajaniemi S. Drug reimbursement systems in EU Member States, Iceland and Norway. Helsinki; 2002. The Social Insurance Institution, Finland, Social security and health reports 54. (accessed 19 January 2010).
16. Hassali MA, Shafie AA, Jamshed S, et al. Consumers' views on generic medicines: A review of the literature. Int J Pharm Pract 2009; 17: 79-88.
17. Lahnajärvi L, Klaukka T, Enlund H. Ahvenanmaa - itsehallittua lääkekulutusta. Social Insurance Institution: Finland, 1997.
18. The Social Insurance Institution, Finland. Generic substitution in 2008. (accessed 19 January 2010).
19. Iosifescu A, Halm EA, McGinn T, et al. Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ Couns 2008; 73: 377-383. DOI: 10.1016/j.pec.2008.07.012.
20. Mott DA, Cline RR. Exploring generic drug use behavior: The role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care 2002; 40: 662-674.
21. Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharm Pract 2008; 6: 93-95.
22. Mäntyselkä PT, Turunen JH, Ahonen RS, et al. Chronic pain and poor self-rated health. JAMA 2003; 290: 2435-2442.
23. Hämeen-Anttila K, Lindell-Osuagwu L, Sepponen K, et al. Factors associated with medicine use among children aged under 12 years-a population survey in Finland. Pharmacoepidemiol Drug Saf 2010; 19: 400-407. DOI: 10.1002/pds.1887.